Total Payments
$1,855
2024 Payments
$290.83
Companies
22
Transactions
36
Medicare Patients
8,610
Medicare Billing
$844,136
Payment Breakdown by Category
Food & Beverage$1,840 (99.2%)
Education$14.63 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,840 | 35 | 99.2% |
| Education | $14.63 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avadel Specialty Pharmaceuticals, LLC | $313.71 | 3 | $0 (2018) |
| NeoTract Inc. | $159.78 | 1 | $0 (2018) |
| Boston Scientific Corporation | $146.13 | 1 | $0 (2019) |
| Endocare, Inc. | $132.80 | 1 | $0 (2017) |
| Photocure Inc | $130.32 | 2 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2018) |
| BIOPROTECT MEDICAL, INC. | $114.20 | 1 | $0 (2024) |
| Augmenix, Inc. | $111.05 | 1 | $0 (2018) |
| NxThera, Inc. | $99.61 | 1 | $0 (2017) |
| PFIZER INC. | $80.73 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $290.83 | 7 | BIOPROTECT MEDICAL, INC. ($114.20) |
| 2023 | $21.20 | 1 | Tolmar, Inc. ($21.20) |
| 2022 | $134.34 | 6 | UROVANT SCIENCES INC ($47.36) |
| 2021 | $37.75 | 2 | UROGEN PHARMA, INC. ($25.46) |
| 2019 | $188.40 | 4 | Boston Scientific Corporation ($146.13) |
| 2018 | $756.63 | 9 | Avadel Specialty Pharmaceuticals, LLC ($313.71) |
| 2017 | $425.73 | 7 | Endocare, Inc. ($132.80) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $26.11 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $114.20 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 06/14/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $55.88 | General |
| Category: Urology | ||||||
| 02/10/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Oncology | ||||||
| 04/11/2023 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Prostate Cancer | ||||||
| 09/15/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: Oncology | ||||||
| 07/19/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $27.45 | General |
| Category: Urology | ||||||
| 07/11/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Prostate Cancer | ||||||
| 06/08/2022 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/10/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $19.91 | General |
| Category: Urology | ||||||
| 11/18/2021 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Prostate Cancer | ||||||
| 09/09/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/12/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $146.13 | General |
| Category: THERAPIES | ||||||
| 09/09/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/28/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: UROLOGY | ||||||
| 10/15/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: UROLOGY | ||||||
| 09/11/2018 | Augmenix, Inc. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $111.05 | General |
| Category: Oncology | ||||||
| 08/30/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | Cash or cash equivalent | $104.57 | General |
| Category: Urology | ||||||
| 08/30/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | Cash or cash equivalent | $104.57 | General |
| Category: Urology | ||||||
| 08/30/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | Cash or cash equivalent | $104.57 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 2,354 | 5,941 | $745,145 | $232,336 |
| 2022 | 12 | 2,516 | 7,857 | $603,590 | $253,326 |
| 2021 | 12 | 2,243 | 6,171 | $506,022 | $219,269 |
| 2020 | 11 | 1,497 | 2,661 | $361,415 | $139,205 |
Total Patients
8,610
Total Services
22,630
Medicare Billing
$844,136
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 479 | 900 | $252,220 | $95,151 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 572 | 966 | $192,540 | $70,213 | 36.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 58 | 75 | $42,930 | $16,243 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 123 | 123 | $43,850 | $15,735 | 35.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 109 | $40,875 | $14,667 | 35.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 417 | 580 | $110,200 | $5,638 | 5.1% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 13 | 2,150 | $7,740 | $4,772 | 61.7% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 16 | 52 | $16,900 | $4,140 | 24.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 585 | 870 | $17,400 | $3,410 | 19.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 53 | $4,740 | $1,596 | 33.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 63 | 63 | $15,750 | $770.93 | 4.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 749 | 1,308 | $170,040 | $95,419 | 56.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 348 | 597 | $95,520 | $64,894 | 67.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 23 | 148 | $55,500 | $20,502 | 36.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 55 | 84 | $46,200 | $20,254 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 129 | 129 | $27,090 | $17,001 | 62.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 55 | 168 | $15,120 | $8,151 | 53.9% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2022 | 17 | 3,650 | $13,140 | $7,955 | 60.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2022 | 20 | 83 | $26,975 | $6,541 | 24.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 426 | 594 | $112,860 | $5,575 | 4.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 612 | 950 | $19,000 | $3,765 | 19.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 23 | 87 | $7,395 | $2,606 | 35.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 59 | 59 | $14,750 | $664.51 | 4.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 572 | 1,006 | $130,780 | $76,745 | 58.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 361 | 512 | $81,970 | $59,714 | 72.8% |
About Dr. Sunil Patel, M.D
Dr. Sunil Patel, M.D is a Urology healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366419202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Patel, M.D has received a total of $1,855 in payments from pharmaceutical and medical device companies, with $290.83 received in 2024. These payments were reported across 36 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,840).
As a Medicare-enrolled provider, Patel has provided services to 8,610 Medicare beneficiaries, totaling 22,630 services with total Medicare billing of $844,136. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Fairfax, VA
- Active Since 02/28/2006
- Last Updated 04/23/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1366419202
Products in Payments
- Noctiva (Drug) $313.71
- UroLift (Device) $159.78
- GENERAL THERAPIES (Device) $146.13
- Endocare Cryocare System (Medical Supply) $132.80
- Erleada (Drug) $125.00
- Cysview (Drug) $118.46
- BIOPROTECT BALLOON IMPLANT SYSTEM (Device) $114.20
- SpaceOAR (Device) $111.05
- Rezum (Device) $99.61
- ELIGARD (Drug) $80.45
- ERLEADA (Drug) $58.12
- Optilume BPH Drug Coated Balloon Catheter (Device) $55.88
- GEMTESA (Drug) $47.36
- IBRANCE (Drug) $44.00
- MYRBETRIQ (Drug) $36.88
- Velara RF (Device) $32.53
- JELMYTO (Drug) $25.46
- LINZESS (Drug) $24.88
- LUPRON DEPOT (Drug) $24.69
- PADCEV (Biological) $22.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Fairfax
Simon Chung, Md, MD
Urology — Payments: $14,885
Urology $14,885
Eric Choe, Md, MD
Urology — Payments: $7,878
Urology $7,878
Dr. Robert Hart, M.d, M.D
Urology — Payments: $5,153
Urology $5,153
Edmond Paquette, Md, MD
Urology — Payments: $3,715
Urology $3,715
Kenneth Lim, Md, MD
Urology — Payments: $2,757
Urology $2,757
Dr. Todd Tescher, M.d, M.D
Urology — Payments: $2,659
Urology $2,659